Materialise NV (MTLS) — 6-K Filings

6-K Filings (18)

• 6-K Filing — Apr 7, 2026
• 6-K Filing — Dec 2, 2025
• 6-K Filing — Nov 20, 2025
• Materialise NV Adds Euronext Brussels Listing — Nov 18, 2025 Risk: low
  On November 18, 2025, Materialise NV announced the publication of a Listing Prospectus in relation to the additional listing of its ordinary shares on Euronext
• 6-K Filing — Nov 14, 2025
• Materialise NV Plans Euronext Brussels Listing — Oct 30, 2025 Risk: low
  On October 30, 2025, Materialise NV announced its intention to list its ordinary shares on Euronext Brussels, in addition to its existing Nasdaq listing of Amer
• Materialise NV Reports Q3 Results — Oct 28, 2025 Risk: low
  Materialise NV announced its third-quarter results on October 28, 2025. The company, headquartered in Leuven, Belgium, filed a Form 6-K report detailing its per
• Materialise NV Reports Q2 2025 Financial Results — Jul 24, 2025 Risk: low
  Materialise NV announced its financial results for the second quarter of 2025 on July 24, 2025. The company, a leader in additive manufacturing and medical soft
• Materialise NV Announces Shareholder Meeting Results — Jun 12, 2025 Risk: low
  On June 12, 2025, Materialise NV announced the results of its annual and extraordinary general meetings of shareholders held on June 3, 2025. Key resolutions pa
• Materialise NV to Hold Shareholder Meetings June 12 — May 16, 2025 Risk: low
  Materialise NV announced its Annual Shareholders' Meeting and Extraordinary Shareholders' Meeting will be held on June 12, 2025. The agenda includes the approva
• Materialise NV Reports Q1 2025 Financial Results — Apr 24, 2025 Risk: low
  Materialise NV announced its first quarter 2025 financial results on April 24, 2025. The company, a leader in additive manufacturing and medical software, repor
• Materialise NV Reports Q4 and Full Year 2024 Results — Feb 20, 2025 Risk: low
  Materialise NV announced its fourth quarter and full year 2024 results on February 20, 2025. The company, a leader in additive manufacturing and medical softwar
• Materialise NV Reports Q3 2024 Financial Results — Oct 24, 2024 Risk: low
  Materialise NV announced its third quarter 2024 financial results on October 24, 2024. The company, a leader in additive manufacturing and medical software, rep
• Materialise NV Reports Q2 2024 Financial Results — Jul 31, 2024 Risk: low
  Materialise NV announced its second quarter 2024 financial results on July 31, 2024. The company, a leader in additive manufacturing and medical software, repor
• Materialise NV Shareholders Approve Dividend and Director Reappointments — Jun 7, 2024 Risk: low
  Materialise NV announced the results of its 2024 Annual General Shareholders' Meeting held on June 7, 2024. Key resolutions included the approval of the annual
• Materialise NV Sets Annual Shareholder Meeting for June 4 — May 22, 2024 Risk: low
  Materialise NV announced its Annual Shareholders' Meeting will be held on June 4, 2024, in Leuven, Belgium. The agenda includes the approval of the annual accou
• Materialise NV Reports Q1 2024 Financial Results — Apr 25, 2024 Risk: low
  Materialise NV announced its first quarter 2024 financial results on April 25, 2024. The company, a provider of additive manufacturing and medical software and
• Materialise NV Files 6-K for Q4 and Full Year 2023 Results — Feb 21, 2024 Risk: low
  Materialise NV (NASDAQ:MTLS) filed a 6-K on February 21, 2024, reporting its Fourth Quarter and Full Year 2023 financial results. The filing indicates that the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX